Muthu Pharmacy Profile
Key Indicators
- Authorised Capital ₹ 7.80 M
as on 24-10-2024
- Paid Up Capital ₹ 6.52 M
as on 24-10-2024
- Company Age 17 Year, 7 Months
- Last Filing with ROC 31 Mar 2023
- Satisfied Charges ₹ 45.00 M
as on 24-10-2024
- Revenue -2.35%
(FY 2023)
- Profit 721.54%
(FY 2023)
- Ebitda 66.76%
(FY 2023)
- Net Worth 9.61%
(FY 2023)
- Total Assets -6.43%
(FY 2023)
About Muthu Pharmacy
The Company is engaged in the Fmcg Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 7.80 M and a paid-up capital of Rs 6.52 M.
The company has closed loans amounting to ₹4.50 Cr, and has no open charges as per Ministry of Corporate Affairs (MCA) records.
Egappan Gnanam, Gnanam Muthuraman, and Gnanam Kalyani serve as directors at the Company.
- CIN/LLPIN
U24230TN2007PTC063047
- Company No.
063047
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
09 Apr 2007
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Chennai
Industry
Company Details
- Location
Chennai, Tamil Nadu, India
- Telephone
- Email Address
- Website
- Social Media-
- Apps
Who are the key members and board of directors at Muthu Pharmacy?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Gnanam Muthuraman  | Managing Director | 09-Apr-2007 | Current |
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Egappan Gnanam | Director | 09-Apr-2007 | Current |
| Gnanam Kalyani | Director | 30-Jun-2010 | Current |
Financial Performance and Corporate Structure Insights of Muthu Pharmacy.
Muthu Pharmacy Private Limited, for the financial year ended 2023, experienced Minor drop in revenue, with a 2.35% decrease. The company also saw a substantial improvement in profitability, with a 721.54% increase in profit. The company's net worth moved up by a moderate rise of 9.61%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Muthu Pharmacy?
In 2023, Muthu Pharmacy had a promoter holding of 62.29% and a public holding of 37.71%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Magnetech Elevators Private Limited
Active 6 years 9 monthsEgappan Gnanam and Gnanam Muthuraman are mutual person
Muthu Hospitals Private Limited
Active 1 year 7 monthsEgappan Gnanam, Gnanam Muthuraman and 1 more are mutual person
Muthu Pharma Agencies Private Limited
Active 26 years 8 monthsEgappan Gnanam, Gnanam Muthuraman and 1 more are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Hdfc Bank Limited Creation Date: 12 Mar 2009 | ₹2.50 Cr | Satisfied |
Axis Bank Limited Creation Date: 01 Mar 2008 | ₹2.00 Cr | Satisfied |
How Many Employees Work at Muthu Pharmacy?
Muthu Pharmacy has a workforce of 118 employees as of Apr 01, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Muthu Pharmacy, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Muthu Pharmacy's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
